OGN vs SPOK · P/E 3.4, rev $3.02B vs P/E 17, rev $68.2M
Organon & Co (OGN) versus Spok Holdings Inc (SPOK) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Spok Holdings Inc (SPOK) is a health information services company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SPOK revenue for 2026-06-30 was $68.2M. Net income was $6.1M. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
Not investment advice. Open the OGN and SPOK stock pages for the full models.
Not investment advice.